Formation and clearance of active and inactive metabolites of opiates in humans

The results of recent investigations of the analgesic and the nonanalgesic effects of opioid glucuronides are relevant to the research on drug abuse in forensic toxicology. As has been shown for heroin, knowledge of the state of distribution and elimination of active and inactive metabolites and glu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Aderjan, Rolf (VerfasserIn) , Skopp, Gisela (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1998
In: Therapeutic drug monitoring
Year: 1998, Jahrgang: 20, Heft: 5, Pages: 561-569
ISSN:1536-3694
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/drug-monitoring/fulltext/1998/10000/formation_and_clearance_of_active_and_inactive.20.aspx
Volltext
Verfasserangaben:Rolf E. Aderjan, G. Skopp

MARC

LEADER 00000caa a2200000 c 4500
001 185619552X
003 DE-627
005 20240311143650.0
007 cr uuu---uuuuu
008 230815s1998 xx |||||o 00| ||eng c
035 |a (DE-627)185619552X 
035 |a (DE-599)KXP185619552X 
035 |a (OCoLC)1425879426 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Aderjan, Rolf  |d 1944-  |e VerfasserIn  |0 (DE-588)11816631X  |0 (DE-627)694728748  |0 (DE-576)291748465  |4 aut 
245 1 0 |a Formation and clearance of active and inactive metabolites of opiates in humans  |c Rolf E. Aderjan, G. Skopp 
264 1 |c 1998 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.08.2023 
520 |a The results of recent investigations of the analgesic and the nonanalgesic effects of opioid glucuronides are relevant to the research on drug abuse in forensic toxicology. As has been shown for heroin, knowledge of the state of distribution and elimination of active and inactive metabolites and glucuronides offers new possibilities in forensic interpretation of analytic results. Because of similar metabolic degradation, calculation of the time-dependent ratio of the concentration of morphine and its glucuronide metabolites in blood or serum allows a rough estimation of increased dosage and of time elapsed since the last application. Drug effects can be examined with respect to individual case histories, including overdose and survival time if the patient died. However, different methods of administration and the strong influence of different volumes or compartments of distribution of parent compounds and metabolites on concentrations in human body tissues require careful use of glucuronide concentration data. - In Germany, dihydrocodeine (DHC) is prescribed as a heroin substitute, and relative overdoses are needed to be effective. DHC metabolism was studied in three patients who died from overdoses. All metabolites (dihydrocodeine-6-glucuronide[DHC6], nor-DHC [NDHC], dihydromorphine [DHM], nor-DHM [NDHM], and DHM-3-and 6-glucuronide [DHM3G, DHM6G]) were determined using HPLC and fluorescence detection. Concentrations of DHM (0.16 mg/L to 0.22 mg/L serum) were found. The DHM glucuronide ratios were similar to those of morphine. Receptor binding studies showed that the binding affinity of DHM to porcine µ-receptor was higher than that of morphine, and DHM6G's binding affinity was as high as that of morphine-6-glucuronide (M6G). Metabolites may play an important role in the effectiveness of DHC in substitution and toxicity. Because of enzyme polymorphism, the formation of DHC poses a risk for proper dosage in patients who are either poor or extensive metabolizers. The distribution of opioid glucuronide in cerebral spinal fluid in relation to transcellular transport in central nervous tissue is discussed with respect to the receptor binding of opiates and drug effect. 
700 1 |a Skopp, Gisela  |d 1951-  |e VerfasserIn  |0 (DE-588)1060738538  |0 (DE-627)800969413  |0 (DE-576)164452346  |4 aut 
773 0 8 |i Enthalten in  |t Therapeutic drug monitoring  |d Philadelphia, Pa. : Lippincott Williams & Wilkins, 1979  |g 20(1998), 5, Seite 561-569  |h Online-Ressource  |w (DE-627)330079239  |w (DE-600)2048919-5  |w (DE-576)094529795  |x 1536-3694  |7 nnas  |a Formation and clearance of active and inactive metabolites of opiates in humans 
773 1 8 |g volume:20  |g year:1998  |g number:5  |g pages:561-569  |g extent:9  |a Formation and clearance of active and inactive metabolites of opiates in humans 
856 4 0 |u https://journals.lww.com/drug-monitoring/fulltext/1998/10000/formation_and_clearance_of_active_and_inactive.20.aspx  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230815 
993 |a Article 
994 |a 1998 
998 |g 1060738538  |a Skopp, Gisela  |m 1060738538:Skopp, Gisela  |d 910000  |d 912100  |e 910000PS1060738538  |e 912100PS1060738538  |k 0/910000/  |k 1/910000/912100/  |p 2  |y j 
998 |g 11816631X  |a Aderjan, Rolf  |m 11816631X:Aderjan, Rolf  |d 910000  |d 912100  |d 50000  |e 910000PA11816631X  |e 912100PA11816631X  |e 50000PA11816631X  |k 0/910000/  |k 1/910000/912100/  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN185619552X  |e 4366272725 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Rolf E. Aderjan, G. Skopp"]},"relHost":[{"part":{"text":"20(1998), 5, Seite 561-569","extent":"9","issue":"5","year":"1998","pages":"561-569","volume":"20"},"note":["Gesehen am 11.06.2019"],"title":[{"title_sort":"Therapeutic drug monitoring","title":"Therapeutic drug monitoring","subtitle":"official journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"issn":["1536-3694"],"zdb":["2048919-5"],"eki":["330079239"]},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"1979","publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar]","publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedDisp":"1979-"}],"recId":"330079239","pubHistory":["1.1979 -"],"disp":"Formation and clearance of active and inactive metabolites of opiates in humansTherapeutic drug monitoring"}],"origin":[{"dateIssuedKey":"1998","dateIssuedDisp":"1998"}],"note":["Gesehen am 15.08.2023"],"person":[{"given":"Rolf","role":"aut","roleDisplay":"VerfasserIn","display":"Aderjan, Rolf","family":"Aderjan"},{"role":"aut","given":"Gisela","roleDisplay":"VerfasserIn","display":"Skopp, Gisela","family":"Skopp"}],"title":[{"title_sort":"Formation and clearance of active and inactive metabolites of opiates in humans","title":"Formation and clearance of active and inactive metabolites of opiates in humans"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["185619552X"]},"language":["eng"],"physDesc":[{"extent":"9 S."}],"recId":"185619552X"} 
SRT |a ADERJANROLFORMATIONA1998